Medication regimen complexity in ambulatory older adults with heart failure
- PMID: 28442898
- PMCID: PMC5396835
- DOI: 10.2147/CIA.S130832
Medication regimen complexity in ambulatory older adults with heart failure
Abstract
Purpose: Heart failure prevalence is increasing in older adults, and polypharmacy is a major problem in this population. We compared medication regimen complexity using the validated patient-level Medication Regimen Complexity Index (pMRCI) tool in "young-old" (60-74 years) versus "old-old" (75-89 years) patients with heart failure. We also compared pMRCI between patients with ischemic cardiomyopathy (ISCM) versus nonischemic cardiomyopathy (NISCM).
Patients and methods: Medication lists were retrospectively abstracted from the electronic medical records of ambulatory patients aged 60-89 years with heart failure. Medications were categorized into three types - heart failure prescription medications, other prescription medications, and over-the-counter (OTC) medications - and scored using the pMRCI tool.
Results: The study evaluated 145 patients (n=80 young-old, n=65 old-old, n=85 ISCM, n=60 NISCM, mean age 73±7 years, 64% men, 81% Caucasian). Mean total pMRCI scores (32.1±14.4, range 3-84) and total medication counts (13.3±4.8, range 2-30) were high for the entire cohort, of which 72% of patients were taking eleven or more total medications. Total and subtype pMRCI scores and medication counts did not differ significantly between the young-old and old-old groups, with the exception of OTC medication pMRCI score (6.2±4 young-old versus 7.8±5.8 old-old, P=0.04). With regard to heart failure etiology, total pMRCI scores and medication counts were significantly higher in patients with ISCM versus NISCM (pMRCI score 34.5±15.2 versus 28.8±12.7, P=0.009; medication count 14.1±4.9 versus 12.2±4.5, P=0.008), which was largely driven by other prescription medications.
Conclusion: Medication regimen complexity is high in older adults with heart failure, and differs based on heart failure etiology. Additional work is needed to address polypharmacy and to determine if medication regimen complexity influences adherence and clinical outcomes in this population.
Keywords: aged; elderly; geriatric; heart failure; medication complexity.
Conflict of interest statement
Disclosure This work was presented in part as a poster presentation at the International Society for Heart and Lung Transplantation 36th Annual Meeting and Scientific Sessions, April 27–30, 2016, Washington, DC.50 The authors report no conflicts of interest in this work.
Similar articles
-
Evaluating Patient-Level Medication Regimen Complexity Over Time in Heart Transplant Recipients.Ann Pharmacother. 2016 Nov;50(11):926-934. doi: 10.1177/1060028016657552. Epub 2016 Jul 19. Ann Pharmacother. 2016. PMID: 27371949
-
Patient-Level Medication Regimen Complexity in Patients With HIV.Ann Pharmacother. 2014 Sep;48(9):1129-1137. doi: 10.1177/1060028014539642. Epub 2014 Jun 17. Ann Pharmacother. 2014. PMID: 24939633
-
Multimorbidity and medication complexity: New challenges in heart transplantation.Clin Transplant. 2019 Oct;33(10):e13682. doi: 10.1111/ctr.13682. Epub 2019 Aug 28. Clin Transplant. 2019. PMID: 31368585 Clinical Trial.
-
Polypharmacy in heart failure patients.Curr Heart Fail Rep. 2014 Jun;11(2):212-9. doi: 10.1007/s11897-014-0186-8. Curr Heart Fail Rep. 2014. PMID: 24493574 Review.
-
Medication Complexity Among Older Adults with HF: How Can We Assess Better?Drugs Aging. 2022 Nov;39(11):851-861. doi: 10.1007/s40266-022-00979-2. Epub 2022 Oct 13. Drugs Aging. 2022. PMID: 36227408 Free PMC article. Review.
Cited by
-
Characteristics and management of very elderly patients with heart failure: a retrospective, population cohort study.ESC Heart Fail. 2023 Feb;10(1):295-302. doi: 10.1002/ehf2.14191. Epub 2022 Oct 8. ESC Heart Fail. 2023. PMID: 36208123 Free PMC article.
-
Aging Model for Analyzing Drug-Induced Proarrhythmia Risks Using Cardiomyocytes Differentiated from Progeria-Patient-Derived Induced Pluripotent Stem Cells.Int J Mol Sci. 2023 Jul 26;24(15):11959. doi: 10.3390/ijms241511959. Int J Mol Sci. 2023. PMID: 37569335 Free PMC article.
-
Definition of Polypharmacy in Heart Failure: A Scoping Review of the Literature.Cardiol Res. 2024 Apr;15(2):75-85. doi: 10.14740/cr1636. Epub 2024 Apr 15. Cardiol Res. 2024. PMID: 38645827 Free PMC article.
-
Age- and sex-matched comparison of diet quality in patients with heart failure to similarly aged healthy older adults.J Nutr Sci. 2021 Aug 18;10:e65. doi: 10.1017/jns.2021.51. eCollection 2021. J Nutr Sci. 2021. PMID: 34527223 Free PMC article.
-
Medication regimen complexity on hospital admission in patients with advanced chronic conditions in need of palliative care.Eur J Hosp Pharm. 2019 Sep;26(5):262-267. doi: 10.1136/ejhpharm-2017-001478. Epub 2018 Apr 26. Eur J Hosp Pharm. 2019. PMID: 31656613 Free PMC article.
References
-
- Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics – 2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–e322. - PubMed
-
- Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J. 1997;133(6):703–712. - PubMed
-
- Riles EM, Jain AV, Fendrick AM. Medication adherence and heart failure. Curr Cardiol Rep. 2014;16(3):458. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical